Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
OncoSil Medical Ltd (OSL) Share Price & Analysis
3 Followers
OSL Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.02
Previous CloseAU$0.01
Volume122.50K
Average Volume (3M)N/A
Market Cap
AU$13.27M
Enterprise ValueAU$5.52M
Total Cash (Recent Filing)AU$11.37M
Total Debt (Recent Filing)AU$304.21K
Price to Earnings (P/E)-1.4
Beta0.86
Next Earnings
Aug 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,255,541,132
10 Day Avg. Volume1,944,458
30 Day Avg. VolumeN/A
Standard Deviation0.22
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OncoSil Medical Ltd News
PremiumCompany Announcements
OncoSil Medical Issues Millions of Unquoted Options
PremiumCompany Announcements
OncoSil Medical Applies for New ASX Quotation
PremiumCompany Announcements
OncoSil Medical Issues 70.4M Unquoted Options
PremiumCompany Announcements
OncoSil Medical Expands Market Presence
PremiumCompany Announcements
OncoSil Shareholders Approve Key ResolutionsPremiumCompany Announcements
OncoSil Medical Issues 170M Unquoted Options
PremiumCompany Announcements
OncoSil Medical New Securities Quotation
PremiumCompany Announcements
OncoSil Medical Issues 70 Million Unquoted OptionsOptions Prices
Currently, No data available
---
Ownership Overview
3.33% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
96.67% Public Companies and
Individual Investors
OSL FAQ
What was OncoSil Medical Ltd’s price range in the past 12 months?
OncoSil Medical Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is OncoSil Medical Ltd’s market cap?
Currently, no data Available
When is OncoSil Medical Ltd’s upcoming earnings report date?
OncoSil Medical Ltd’s upcoming earnings report date is Aug 22, 2024 which is in 93 days.
How were OncoSil Medical Ltd’s earnings last quarter?
OncoSil Medical Ltd released its earnings results on Feb 28, 2024. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is OncoSil Medical Ltd overvalued?
According to Wall Street analysts OncoSil Medical Ltd’s price is currently Overvalued.
Does OncoSil Medical Ltd pay dividends?
OncoSil Medical Ltd does not currently pay dividends.
What is OncoSil Medical Ltd’s EPS estimate?
OncoSil Medical Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoSil Medical Ltd have?
OncoSil Medical Ltd has 3,317,109,600 shares outstanding.
What happened to OncoSil Medical Ltd’s price movement after its last earnings report?
OncoSil Medical Ltd reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of OncoSil Medical Ltd?
Currently, no hedge funds are holding shares in AU:OSL
---
OncoSil Medical Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:OSL Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-237.87%
Trailing 12-Months
Asset Growth
-15.54%
Trailing 12-Months
Company Description
OncoSil Medical Ltd
OncoSil Medical Ltd is a medical device company focused on localized radiation treatments for patients with pancreatic and bile duct cancer. Its product includes OncoSil, a silicon and phosphorus (p32) beta emitter radiation therapy for the treatment of pancreatic cancer.
---
Rhythm Biosciences Ltd.
―
Recce Pharmaceuticals Ltd.
―
Micro-X Ltd.
―
Regeneus Ltd.
―
---